Related Experiment Videos
A homogeneous fluorescent immunoassay for human immunoglobulin M
Clinical Chemistry
|May 1, 1981
Summary
This study presents a novel fluorescent immunoassay for quantifying human immunoglobulin M (IgM). The assay utilizes a beta-galactosidase-linked substrate and competitive binding for sensitive IgM detection.
Area of Science:
- Biochemistry
- Immunology
- Analytical Chemistry
Background:
- Accurate quantification of human immunoglobulin M (IgM) is crucial for diagnosing and monitoring various immune-related conditions.
- Existing immunoassays may have limitations in sensitivity, specificity, or ease of use.
- Development of novel, sensitive, and specific assays for IgM is an ongoing area of research.
Purpose of the Study:
- To develop and characterize a homogeneous substrate-labeled fluorescent immunoassay for human IgM.
- To evaluate the assay's performance, including sensitivity, specificity, and working range.
- To provide a reliable method for measuring IgM concentrations in serum samples.
Main Methods:
- A competitive-binding immunoassay format was employed.
- Human IgM was covalently labeled with a fluorogenic substrate for Escherichia coli beta-galactosidase.
- Fluorescence intensity, measured upon enzymatic hydrolysis, was inversely proportional to IgM concentration.
Main Results:
- The assay demonstrated a working range of 0.5 to 5.0 g/L of IgM with a 50-fold serum predilution.
- The assay showed negligible cross-reactivity with human immunoglobulins G (IgG) and A (IgA).
- The fluorescence signal was directly related to the enzymatic activity, which was inhibited by the presence of anti-IgM antibodies.
Conclusions:
- The developed homogeneous substrate-labeled fluorescent immunoassay is a sensitive and specific method for human IgM quantification.
- This assay offers a reliable alternative for clinical diagnostics and research involving IgM levels.
- The assay's design minimizes cross-reactivity, enhancing its diagnostic utility.